Respiratory pressure meter

Last updated

A respiratory pressure meter measures the maximum inspiratory and expiratory pressures that a patient can generate at either the mouth (MIP and MEP) or inspiratory pressure a patient can generate through their nose via a sniff maneuver (SNIP). These measurements require patient cooperation and are known as volitional tests of respiratory muscle strength. Handheld devices displaying the measurement achieved in centimetres of water pressure (cmH2O) and the pressure trace created, allow quick patient testing away from the traditional pulmonary laboratory and are useful for ward-based, out-patient and preoperative assessment, as well as for use by pulmonologists and physiotherapists.

Contents

The principal advantage of volitional tests is that they give an estimate of inspiratory or expiratory muscle strength, are simple to perform, and are well tolerated by patients. [1]

Causes of respiratory muscle impairment

Impairment of inspiratory and expiratory respiratory muscles is a common clinical finding, not only in patients with neuromuscular disease but also in patients with primary disease of the lung parenchyma or airways. [2]

Patients with neuromuscular or metabolic diseases are at risk of developing skeletal and respiratory muscle weakness. In neuromuscular diseases close attention should be paid to the involvement of both the inspiratory and the expiratory muscles. In patients with multiple sclerosis for example, abdominal (and hence expiratory) muscle weakness is a hallmark of the disease, and is related to clinical problems such as mucus retention. In lung diseases, such as cystic fibrosis and COPD, inspiratory muscle weakness is often present. When patients are malnourished or exposed to corticosteroids, weakness of the respiratory muscles is also seen in these diseases.

Respiratory pressure meter Respiratory pressure meter device.jpg
Respiratory pressure meter

Measuring respiratory muscle strength is a long-established method of assessing the mechanics of breathing. Respiratory muscle dysfunction (i.e., reduced strength or endurance) should be distinguished from lung function abnormalities and measured separately. Measurement of respiratory muscle function is important in the diagnosis of respiratory muscle disease or respiratory muscle dysfunction. It may also be helpful in the assessment of the impact of chronic diseases or their treatment on the respiratory muscles. [3]

Types of tests

Maximal inspiratory pressure (MIP), also called PImax

Maximal inspiratory pressure (MIP), also known as negative inspiratory force (NIF), is the maximum pressure that can be generated against an occluded (closed or obstructed) airway beginning at functional residual capacity (the volume of air present in the lungs at the end of passive expiration). It is a marker of respiratory muscle function and strength, [4] represented by cmH2O and measured with a manometer. MIP is an important and noninvasive index of diaphragm strength and an independent tool for diagnosing many illnesses. [5] Typical MIPs in adult males can be estimated from the equation MIP = 142 - (1.03 x Age) cmH2O, where age is in years. [6]

This test is performed at RV (Residual Volume), the amount of air remaining in the patient's lungs after fully exhaling. The patient then inhales as hard and as fast as possible with maximal sustained effort for longer than 1 second, and the pressure is the highest achieved during that time.[ citation needed ]

Maximal expiratory pressure (MEP), also called PEmax

This test is performed at TLC (total lung capacity). The patient inhales fully to prepare, and then exhales as hard and as fast as possible with maximal sustained effort for longer than 1 second. The exhaled pressure is the highest achieved during that time.[ citation needed ]

Sniff nasal inspiratory pressure (SNIP)

Sniff nasal inspiratory pressure (SNIP) refers to short, sharp voluntary inspiratory maneuver (inhalation) through one or both un-occluded (not closed or obstructed) nostrils. The tests are performed at FRC (functional residual capacity), at the end of tidal expiration. The measurement recorded is the peak pressure. This test is particularly suited to neuromuscular weakness because it doesn't require a mouthpiece and because it is easily mastered by the vast majority of patients. [7]

Related Research Articles

<span class="mw-page-title-main">Lung volumes</span> Volume of air in the lungs

Lung volumes and lung capacities refer to the volume of air in the lungs at different phases of the respiratory cycle.

<span class="mw-page-title-main">Positive airway pressure</span> Mechanical ventilation in which airway pressure is always above atmospheric pressure

Positive airway pressure (PAP) is a mode of respiratory ventilation used in the treatment of sleep apnea. PAP ventilation is also commonly used for those who are critically ill in hospital with respiratory failure, in newborn infants (neonates), and for the prevention and treatment of atelectasis in patients with difficulty taking deep breaths. In these patients, PAP ventilation can prevent the need for tracheal intubation, or allow earlier extubation. Sometimes patients with neuromuscular diseases use this variety of ventilation as well. CPAP is an acronym for "continuous positive airway pressure", which was developed by Dr. George Gregory and colleagues in the neonatal intensive care unit at the University of California, San Francisco. A variation of the PAP system was developed by Professor Colin Sullivan at Royal Prince Alfred Hospital in Sydney, Australia, in 1981.

<span class="mw-page-title-main">Exhalation</span> Flow of the respiratory current out of an organism

Exhalation is the flow of the breath out of an organism. In animals, it is the movement of air from the lungs out of the airways, to the external environment during breathing. This happens due to elastic properties of the lungs, as well as the internal intercostal muscles which lower the rib cage and decrease thoracic volume. As the thoracic diaphragm relaxes during exhalation it causes the tissue it has depressed to rise superiorly and put pressure on the lungs to expel the air. During forced exhalation, as when blowing out a candle, expiratory muscles including the abdominal muscles and internal intercostal muscles generate abdominal and thoracic pressure, which forces air out of the lungs.

<span class="mw-page-title-main">Spirometry</span> Pulmonary function test

Spirometry is the most common of the pulmonary function tests (PFTs). It measures lung function, specifically the amount (volume) and/or speed (flow) of air that can be inhaled and exhaled. Spirometry is helpful in assessing breathing patterns that identify conditions such as asthma, pulmonary fibrosis, cystic fibrosis, and COPD. It is also helpful as part of a system of health surveillance, in which breathing patterns are measured over time.

<span class="mw-page-title-main">Respiratory arrest</span> Medical condition

Respiratory arrest is a serious medical condition caused by apnea or respiratory dysfunction severe enough that it will not sustain the body. Prolonged apnea refers to a patient who has stopped breathing for a long period of time. If the heart muscle contraction is intact, the condition is known as respiratory arrest. An abrupt stop of pulmonary gas exchange lasting for more than five minutes may permanently damage vital organs, especially the brain. Lack of oxygen to the brain causes loss of consciousness. Brain injury is likely if respiratory arrest goes untreated for more than three minutes, and death is almost certain if more than five minutes.

<span class="mw-page-title-main">Vital capacity</span> Measure of human lung capacity

Vital capacity (VC) is the maximum amount of air a person can expel from the lungs after a maximum inhalation. It is equal to the sum of inspiratory reserve volume, tidal volume, and expiratory reserve volume. It is approximately equal to Forced Vital Capacity (FVC).

Positive end-expiratory pressure (PEEP) is the pressure in the lungs above atmospheric pressure that exists at the end of expiration. The two types of PEEP are extrinsic PEEP and intrinsic PEEP. Pressure that is applied or increased during an inspiration is termed pressure support.PEEP is a therapeutic parameter set in the ventilator, or a complication of mechanical ventilation with air trapping (auto-PEEP).

The cough reflex occurs when stimulation of cough receptors in the respiratory tract by dust or other foreign particles produces a cough, which causes rapidly moving air which usually remove the foreign material before it reaches the lungs. This typically clears particles from the bronchi and trachea, the tubes that feed air to lung tissue from the nose and mouth. The larynx and carina are especially sensitive. Cough receptors in the surface cells (epithelium) of the respiratory tract are also sensitive to chemicals. Terminal bronchioles and even the alveoli are sensitive to chemicals such as sulfur dioxide gas or chlorine gas.

<span class="mw-page-title-main">Functional residual capacity</span> Volume of air in the lungs at the end of passive expiration

Functional residual capacity (FRC) is the volume of air present in the lungs at the end of passive expiration. At FRC, the opposing elastic recoil forces of the lungs and chest wall are in equilibrium and there is no exertion by the diaphragm or other respiratory muscles.

Air trapping, also called gas trapping, is an abnormal retention of air in the lungs where it is difficult to exhale completely. It is observed in obstructive lung diseases such as asthma, bronchiolitis obliterans syndrome and chronic obstructive pulmonary diseases such as emphysema and chronic bronchitis.

Lung compliance, or pulmonary compliance, is a measure of the lung's ability to stretch and expand. In clinical practice it is separated into two different measurements, static compliance and dynamic compliance. Static lung compliance is the change in volume for any given applied pressure. Dynamic lung compliance is the compliance of the lung at any given time during actual movement of air.

<span class="mw-page-title-main">Obstructive lung disease</span> Category of respiratory disease characterized by airway obstruction

Obstructive lung disease is a category of respiratory disease characterized by airway obstruction. Many obstructive diseases of the lung result from narrowing (obstruction) of the smaller bronchi and larger bronchioles, often because of excessive contraction of the smooth muscle itself. It is generally characterized by inflamed and easily collapsible airways, obstruction to airflow, problems exhaling, and frequent medical clinic visits and hospitalizations. Types of obstructive lung disease include; asthma, bronchiectasis, bronchitis and chronic obstructive pulmonary disease (COPD). Although COPD shares similar characteristics with all other obstructive lung diseases, such as the signs of coughing and wheezing, they are distinct conditions in terms of disease onset, frequency of symptoms, and reversibility of airway obstruction. Cystic fibrosis is also sometimes included in obstructive pulmonary disease.

<span class="mw-page-title-main">Pulmonary function testing</span> Test to evaluate respiratory system

Pulmonary function testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, and tests of pulmonary function. The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease. PFTs are normally performed by a pulmonary function technician, respiratory therapist, respiratory physiologist, physiotherapist, pulmonologist, or general practitioner.

Pulmonary hygiene, also referred to as pulmonary toilet, is a set of methods used to clear mucus and secretions from the airways. The word pulmonary refers to the lungs. The word toilet, related to the French toilette, refers to body care and hygiene; this root is used in words such as toiletry that also relate to cleansing.

Modes of mechanical ventilation are one of the most important aspects of the usage of mechanical ventilation. The mode refers to the method of inspiratory support. In general, mode selection is based on clinician familiarity and institutional preferences, since there is a paucity of evidence indicating that the mode affects clinical outcome. The most frequently used forms of volume-limited mechanical ventilation are intermittent mandatory ventilation (IMV) and continuous mandatory ventilation (CMV). There have been substantial changes in the nomenclature of mechanical ventilation over the years, but more recently it has become standardized by many respirology and pulmonology groups. Writing a mode is most proper in all capital letters with a dash between the control variable and the strategy.

ΔP is a mathematical term symbolizing a change (Δ) in pressure (P).

Continuous mandatory ventilation (CMV) is a mode of mechanical ventilation in which breaths are delivered based on set variables. Still used in the operating room, in previous nomenclature, CMV referred to "controlled mechanical ventilation", a mode of ventilation characterized by a ventilator that makes no effort to sense patient breathing effort. In continuous mandatory ventilation, the ventilator can be triggered either by the patient or mechanically by the ventilator. The ventilator is set to deliver a breath according to parameters selected by the operator. "Controlled mechanical ventilation" is an outdated expansion for "CMV"; "continuous mandatory ventilation" is now accepted standard nomenclature for mechanical ventilation. CMV today can assist or control itself dynamically, depending on the transient presence or absence of spontaneous breathing effort. Thus, today's CMV would have been called ACV in older nomenclature, and the original form of CMV is a thing of the past. But despite continual technological improvement over the past half century, CMV may still be uncomfortable for the patient.

Inverse ratio ventilation (IRV) is not necessarily a mode of mechanical ventilation though it may be referred to as such. IRV is a strategy of ventilating the lungs in such a way that the amount of time the lungs are in inhalation is greater than the amount of time they are in exhalation, allowing for a constant inflation of the lungs, ensuring they remain "recruited". The primary goal for IRV is improved oxygenation by forcing inspiratory time to be greater than expiratory time increasing the mean airway pressure and potentially improving oxygenation. Normal I:E ratio is 5:6, so forcing the I:E to be 2:1, 3:1, 4:1, is the source of the term for the strategy.

Peak inspiratory pressure (PIP) is the highest level of pressure applied to the lungs during inhalation. In mechanical ventilation the number reflects a positive pressure in centimeters of water pressure (cm H2O). In normal breathing, it may sometimes be referred to as the maximal inspiratory pressure (MIPO), which is a negative value.

Dynamic hyperinflation is a phenomenon that occurs when a new breath begins before the lung has reached the static equilibrium volume. In simpler terms, this means that a new breath starts before the usual amount of air has been breathed out, leading to a build-up of air in the lungs, and causing breathing in and out to take place when the lung is nearly full.

References

  1. ATS/ERS Statement on Respiratory Muscle Testing. Am J Respir Crit Care Med Vol 166. pp 518–624, 2002
  2. Diagnostic methods to assess inspiratory and expiratory muscle strength. J Bras Pneumol. 2015;41(2):110-123. Pedro Caruso et al.
  3. Respiratory muscle assessment. Eur Respir Mono 2005, 31, 51 – 57. T. Troosters, R Gosselink, M Decramer
  4. Page 352 in: Irwin, Richard (2008). Procedures, techniques, and minimally invasive monitoring in intensive care medicine. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. ISBN   978-0781778626.
  5. Sachs MC, Enright PL, Hinckley Stukovsky KD, Jiang R, Barr RG, Multi-Ethnic Study of Atherosclerosis Lung Study (2009). "Performance of maximum inspiratory pressure tests and maximum inspiratory pressure reference equations for 4 race/ethnic groups". Respir Care. 54 (10): 1321–8. PMC   3616895 . PMID   19796411.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. Wilson SH, Cooke NT, Edwards RH, Spiro SG (July 1984). "Predicted normal values for maximal respiratory pressures in caucasian adults and children". Thorax. 39 (7): 535–8. doi:10.1136/thx.39.7.535. PMC   459855 . PMID   6463933.
  7. Sniff nasal inspiratory pressure: simple or too simple. Eur Respir J 2006; 27; 881 – 883. J-W Fitting